advertisement
Belda JI 18
Showing records 1 to 18 |
Display all abstracts from Belda JI77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialBelda JI
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMyers JS; Masood I
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialLoscos-Arenas J
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMasood I
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialMermoud A
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesHornbeak DM
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialLozano E
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesBelda JI
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialD'Alessandro E
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesAuffarth G; Jünemann A
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialRebolleda G
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesGiamporcaro JE
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialRodriguez-Agirretxe I
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMartinez-de-la-Casa JM
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trialCanut M; Rodriguez-Calvo PP
Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesAhmed IIK; Voskanyan L
Advances in Therapy 2018; 35: 395-407
77226 Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial Acta Ophthalmologica 2018; 0:
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesKatz LJ
Advances in Therapy 2018; 35: 395-407